U.S. Stock News

NYSE:MP
NYSE:MPMetals and Mining

MP Materials Texas Magnet Bet Tied To Valuation And Policy Support

MP Materials (NYSE:MP) is building a $1.25 billion rare earth magnet manufacturing campus in Texas. The facility is backed by federal, state, and local government support as part of U.S. supply chain policy. The campus is designed to be a major hub for rare earth extraction, processing, magnet production, and recycling. For investors, this marks a shift for MP Materials from primarily producing rare earth materials toward more value-added magnet manufacturing. Rare earth magnets are key...
NYSE:OMC
NYSE:OMCMedia

Is Omnicom Group (OMC) Pricing Reflect Its Cash Flow Outlook And Interpublic Deal Prospects

If you are wondering whether Omnicom Group is offering good value at its current share price, you are not alone. This article will focus on what that price really implies. The stock last closed at US$82.71, with returns of 17.9% over 7 days, 2.9% over 30 days, 1.7% year to date, 2.5% over 1 year, a 0.1% decline over 3 years and 34.7% over 5 years. These figures give you several time frames to think about how the market is currently pricing the business. Recent news coverage of Omnicom has...
NYSE:WWW
NYSE:WWWLuxury

Does Strong 2025 Results And Confident 2026 Guidance Amid Tariff Risks Change The Bull Case For WWW?

Wolverine World Wide, Inc. has reported its fourth-quarter and full-year 2025 results, with sales rising to US$517.5 million for the quarter and US$1.87 billion for the year, alongside higher net income and diluted earnings per share from continuing operations versus the prior year. The company also issued 2026 guidance, targeting revenue of about US$1.96 billion to US$1.99 billion and higher diluted EPS, highlighting management’s confidence despite fresh global tariff uncertainty affecting...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Assessing Kymera Therapeutics (KYMR) Valuation After Equity Offering Losses And Leadership Change

Kymera Therapeutics (KYMR) has put several big issues on the table at once, combining fresh fourth quarter and full year 2025 losses with new equity issuance plans and a key leadership hire. See our latest analysis for Kymera Therapeutics. Despite the larger reported losses and fresh equity plans, Kymera’s recent momentum has been strong, with a 27.61% 1 month share price return and a 156.45% 1 year total shareholder return, suggesting investors are reassessing both risk and potential. If...
NYSE:DUK
NYSE:DUKElectric Utilities

Does Recent Executive Share Sales at Duke Energy (DUK) Reframe Its Long-Term Investment Narrative?

Duke Energy recently disclosed past insider transactions in which EVP & CFO Brian Savoy sold 12,000 shares and SVP Regis T. Repko sold 4,376 shares, drawing attention to executive stock monetization at the utility. Because insider activity can influence how investors interpret management’s confidence and priorities, these sales may shape sentiment around Duke Energy’s longer-term outlook and capital plans. We’ll now examine how this insider selling, against Duke’s sizable investment...
NYSE:PEG
NYSE:PEGIntegrated Utilities

Is It Time To Reassess Public Service Enterprise Group (PEG) After Strong Multi‑Year Gains?

If you are wondering whether Public Service Enterprise Group's current share price reflects its underlying worth, you are not alone. Many investors are asking the same question as the stock gains attention. The shares most recently closed at US$85.97, with returns of 1.9% over 7 days, 8.8% over 30 days, 6.1% year to date, 7.0% over 1 year, 62.5% over 3 years, and 87.4% over 5 years. This provides plenty of data points for a closer look at value. Recent news around Public Service Enterprise...
NYSE:LUV
NYSE:LUVAirlines

Is Southwest Airlines (LUV) Share Price Still Attractive After Strong 1 Year Rally?

If you are wondering whether Southwest Airlines' current share price still offers value, this article will walk through what that price might imply about the company. The stock closed at US$49.89 recently, with returns of 18.7% over the last 30 days, 20.8% year to date and 66.1% over the past year, although the last 7 days show a 9.0% decline and the 5 year return sits at a 7.3% loss. Recent coverage has focused on Southwest Airlines as investors reassess US airline stocks generally,...
NYSE:AEE
NYSE:AEEIntegrated Utilities

Ameren Missouri Bond Sale Reshapes Debt Profile And Funds Grid Investment

Ameren Missouri, a subsidiary of Ameren Corporation, has priced a new public offering of first mortgage bonds. The company plans to use the proceeds to refinance existing debt and fund near term capital expenditures. This financing step is intended to reshape Ameren Missouri's debt profile and support upcoming investment needs. For investors watching Ameren (NYSE: AEE), this bond move sits alongside a share price of $111.44 and multi year returns. The stock is up 2.9% over the past week,...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Is Strong Q4 Revenue And Steady Dividend Policy Altering The Investment Case For Viatris (VTRS)?

Viatris Inc. recently reported fourth-quarter 2025 results with revenue of US$3,703.6 million and a net loss of US$340.1 million, issued 2026 revenue guidance of US$14.45 billion to US$14.95 billion, and affirmed a 2026 dividend policy of US$0.48 per share. Alongside these results, the company highlighted progress in its ophthalmology pipeline with FDA review of MR-141 for presbyopia and continued cost-saving initiatives aimed at making its operations more focused and efficient. We’ll now...
NYSE:TROX
NYSE:TROXChemicals

Tronox Weighs Rare Earth Expansion And New Funding Options Amid Losses

Tronox Holdings (NYSE:TROX) is expanding further into the rare earth supply chain, signaling a push beyond its traditional titanium dioxide business. The company has filed a universal shelf registration, giving it flexibility to raise capital through a range of securities if and when it chooses. At a share price of $7.2, NYSE:TROX has had a mixed return profile, with a 68.6% gain year to date alongside a 46.9% decline over 3 years and a 52.5% decline over 5 years. Over the past month the...
NYSE:APO
NYSE:APODiversified Financial

Is Apollo Global Management (APO) Attractive Again After Recent Share Price Pullback?

Wondering if Apollo Global Management at around US$117 per share is starting to look appealing again, or if the recent weakness is a warning sign for value focused investors like you. The stock is down around 6.5% over the last week, 10.9% over the last month and 20.1% year to date, although the 3 year and 5 year returns of 71.3% and 158.5% still show a very different longer term picture. Recent headlines have focused on Apollo's role as a major alternative asset manager and on how investors...
NYSE:AWR
NYSE:AWRWater Utilities

Rising Revenue but Flat EPS Might Change The Case For Investing In American States Water (AWR)

American States Water Company has reported its fourth-quarter and full-year 2025 results, with sales and revenue rising to US$164.28 million for the quarter and US$658.07 million for the year, and full-year net income reaching US$130.44 million. Despite the revenue and annual earnings increases, quarterly diluted earnings per share from continuing operations were essentially flat at US$0.74 compared with US$0.75 a year earlier, highlighting margin pressures even as the business scales. With...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet Group (TNET) Valuation Check After 2025 Results And Softer 2026 Guidance

TriNet Group (TNET) just released its fourth quarter and full year 2025 results alongside 2026 guidance, including updated revenue, earnings and share repurchase figures that give investors fresh context for the stock. See our latest analysis for TriNet Group. Despite a 3.92% 1 day share price return taking TriNet Group to US$35.75, the 30 day share price return of 43.12% and 1 year total shareholder return of 49.19% indicate that momentum has been fading as the market absorbs softer 2026...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Elanco Animal Health Q4 Loss Deepens And Tests Bullish Profitability Narratives

Elanco Animal Health's Latest Earnings Show Mixed Profitability Signals Elanco Animal Health (ELAN) has wrapped up FY 2025 with fourth quarter revenue of US$1,144 million and basic EPS of a US$0.56 loss, alongside trailing twelve month revenue of US$4.7 billion and basic EPS of a US$0.47 loss. Over recent periods the company has seen quarterly revenue move from US$1,020 million in Q4 2024 to US$1,144 million in Q4 2025, while basic EPS has swung between a profit of US$0.14 in Q1 2025 and a...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Is Liberty Latin America (LILA) Attractive After Years Of Share Price Weakness

If you are wondering whether Liberty Latin America is priced attractively right now, this article will walk through how its current share price stacks up against different ways of thinking about value. The stock closed at US$7.79 most recently, with returns of 0.8% over the last 7 days, 2.2% over 30 days, 7.3% year to date, 12.2% over 1 year, and longer term returns of an 11.0% decline over 3 years and a 40.1% decline over 5 years that many investors will want to put into context. Recent...
NYSE:CPK
NYSE:CPKGas Utilities

How Stronger 2025 Earnings and Reaffirmed 2028 Targets Will Impact Chesapeake Utilities (CPK) Investors

Chesapeake Utilities Corporation recently reported fourth-quarter 2025 results showing sales of US$266.6 million and net income of US$46.1 million, alongside a declared quarterly cash dividend of US$0.685 per share payable on April 6, 2026. The company’s full-year 2025 earnings growth, combined with reaffirmed 2028 earnings guidance of US$7.75 to US$8.00 per share and a 65-year uninterrupted dividend record, underlines its emphasis on consistent income generation for shareholders. Next,...
NYSE:OC
NYSE:OCBuilding

Owens Corning (OC) LTM Net Loss Challenges Bullish Margin Recovery Narratives

Owens Corning FY 2025 earnings snapshot Owens Corning (OC) has wrapped up FY 2025 with Q4 revenue of US$2,142 million and a basic EPS loss of US$3.45, capping a year where trailing 12 month revenue came in at US$10.1 billion and basic EPS was a loss of US$2.24. Over recent quarters, the company has seen quarterly revenue move from US$2,840 million in Q4 2024 to US$2,530 million in Q1 2025, then US$2,747 million in Q2 and US$2,684 million in Q3. Basic EPS swung between a loss of US$3.00 in Q4...
NYSE:DOLE
NYSE:DOLEFood

Dole (DOLE) Margin Squeeze And Q4 Loss Test Bullish Repricing Narrative

Dole (DOLE) FY 2025 earnings headline Dole (DOLE) has rounded out FY 2025 with fourth quarter revenue of US$2.4b and basic EPS of a US$0.02 loss, capping a year in which trailing twelve month revenue came in at US$9.2b and EPS at US$1.02. Over recent quarters the company has seen revenue move from US$2.2b in Q4 2024 to US$2.4b in Q4 2025, while quarterly EPS shifted from US$0.23 to a small loss. This leaves investors weighing solid full year earnings power against softer margin execution in...
NasdaqGS:BOOM
NasdaqGS:BOOMEnergy Services

DMC Global (BOOM) Is Down 25.3% After Wider Q4 Loss And Soft 2026 Outlook Has The Bull Case Changed?

DMC Global Inc. has reported its fourth-quarter 2025 results, with sales falling to US$143.53 million from US$152.37 million a year earlier and swinging from a small net income to a net loss of US$11.16 million. For full-year 2025, the company reduced its net loss to US$13.45 million despite lower sales of US$609.84 million, but management’s first-quarter 2026 guidance flags continued operational pressures and weather-related disruptions that are expected to weigh on near-term...
NasdaqGS:LINC
NasdaqGS:LINCConsumer Services

Why Lincoln Educational Services (LINC) Is Up 16.2% After Raising 2026 Guidance And Expanding Its Campus Footprint

In February 2026, Lincoln Educational Services reported Q4 2025 and full‑year results showing higher revenue of US$142.87 million for the quarter and US$518.24 million for the year, alongside net income of US$12.7 million and US$20 million respectively, and issued 2026 guidance calling for revenue of US$580–590 million and diluted EPS of US$0.64–0.74. Beyond the headline earnings beat, management highlighted double‑digit student start growth, rising operating efficiency, and planned campus...
NYSE:HIMS
NYSE:HIMSHealthcare

How Investors Are Reacting To Hims & Hers Health (HIMS) Softer GLP-1 Outlook And ESOP Share Offering

In late February 2026, Hims & Hers Health reported fourth-quarter 2025 results showing higher sales year on year but slightly lower quarterly profit, issued softer-than-expected Q1 2026 revenue guidance amid regulatory and legal pressure on its compounded semaglutide weight-loss offerings, and filed a US$176.23 million shelf registration tied to an ESOP-related Class A share offering. The company’s outlook now hinges on how it manages FDA scrutiny, a Novo Nordisk patent lawsuit, an SEC...
NYSE:CBRE
NYSE:CBREReal Estate

Will AI-Focused Analyst Upgrades and $4.2 Billion Buybacks Change CBRE Group's (CBRE) Narrative

In the fourth quarter and full year ended December 31, 2025, CBRE Group reported higher sales but lower quarterly earnings per share, while also completing a share repurchase program totaling 43,753,374 shares for about US$4.20 billion since its November 2021 authorization. Alongside this capital return, a series of analyst upgrades highlighting CBRE’s positioning for artificial intelligence and resilient brokerage trends has reframed how investors view the company’s longer-term earnings...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Animal Health CEO Share Sale Highlights Medicated Feed Additives Growth

Phibro Animal Health (NasdaqGM:PAHC) CEO Jack Bendheim recently sold a substantial block of company shares. The sale followed a strong quarterly performance for Phibro Animal Health. Growth in the Medicated Feed Additives portfolio, supported by recent acquisitions, was a key driver in the latest results. The timing of the insider sale after reported operational progress has drawn attention from investors tracking management actions. Phibro Animal Health focuses on animal health and...
NasdaqGM:LAND
NasdaqGM:LANDSpecialized REITs

Gladstone Land (LAND) Q4 FFO Loss Challenges Bullish Recurring Income Narrative

Gladstone Land (LAND) has wrapped up FY 2025 with Q4 total revenue of US$41.6 million, a basic EPS loss of US$0.05, and a net income loss of US$1.8 million, alongside funds from operations of US$0.5 million in losses. Over the last few reported periods, revenue has moved from US$21.2 million in Q4 2024 to US$41.6 million in Q4 2025. Trailing twelve month revenue for the year to Q4 2025 sits at US$88.3 million and basic EPS on the same basis is a loss of US$0.29. For investors, these results...